Researchers have discovered that GPR31, found in certain immune cells in the human gut, plays a key role in responding to bacterial metabolites and activating immune responses. Specifically, in the presence of metabolite pyruvate, these cells extend dendrites to sample the gut environment, detect pathogens, and activate T cells through GPR31. This discovery could inform the development of new drugs, vaccines, and probiotics that enhance gut immunity by targeting this pathway.
